4
Changes in Ownership
Guardant Health, Inc. Filed Acc 0001576280-25-000205
Director sold 26 shares at $49.47 ($1,286)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
POTTER MYRTLE S · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-18 | Sale : show line 1 in the form 10b5-1 | −26 | $49.47 | $1,286 | 18,154 | D |
| Open-market sales · 26 sh · avg $49.47 · $1,286 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-06-18 | Grant or award : show line 2 in the form 10b5-1 Stock Option (Right to Buy) | +6,833 | $50.57 | 2035-06-18 | 6,833 | 6,833 | D |
| 2025-06-18 | Grant or award : show line 3 in the form 10b5-1 Restricted Stock Units | +4,203 | $0.00 | 4,203 | 4,203 | D |
Loading xslF345X05/wk-form4_1750455650.xml…